1. Home
  2. HUMA vs AURA Comparison

HUMA vs AURA Comparison

Compare HUMA & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • AURA
  • Stock Information
  • Founded
  • HUMA 2004
  • AURA 2007
  • Country
  • HUMA United States
  • AURA United States
  • Employees
  • HUMA N/A
  • AURA N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUMA Health Care
  • AURA Health Care
  • Exchange
  • HUMA Nasdaq
  • AURA Nasdaq
  • Market Cap
  • HUMA 679.3M
  • AURA 572.0M
  • IPO Year
  • HUMA N/A
  • AURA 2021
  • Fundamental
  • Price
  • HUMA $5.26
  • AURA $10.96
  • Analyst Decision
  • HUMA Strong Buy
  • AURA Strong Buy
  • Analyst Count
  • HUMA 8
  • AURA 4
  • Target Price
  • HUMA $11.50
  • AURA $23.00
  • AVG Volume (30 Days)
  • HUMA 3.2M
  • AURA 231.8K
  • Earning Date
  • HUMA 11-08-2024
  • AURA 11-15-2024
  • Dividend Yield
  • HUMA N/A
  • AURA N/A
  • EPS Growth
  • HUMA N/A
  • AURA N/A
  • EPS
  • HUMA N/A
  • AURA N/A
  • Revenue
  • HUMA N/A
  • AURA N/A
  • Revenue This Year
  • HUMA N/A
  • AURA N/A
  • Revenue Next Year
  • HUMA $4,615.69
  • AURA N/A
  • P/E Ratio
  • HUMA N/A
  • AURA N/A
  • Revenue Growth
  • HUMA N/A
  • AURA N/A
  • 52 Week Low
  • HUMA $2.08
  • AURA $6.63
  • 52 Week High
  • HUMA $9.97
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 47.00
  • AURA 63.25
  • Support Level
  • HUMA $5.06
  • AURA $10.04
  • Resistance Level
  • HUMA $5.63
  • AURA $10.73
  • Average True Range (ATR)
  • HUMA 0.34
  • AURA 0.49
  • MACD
  • HUMA 0.00
  • AURA -0.05
  • Stochastic Oscillator
  • HUMA 35.65
  • AURA 55.13

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: